Search Results - "Chan, M.W.Y."

Corrigendum to ‘Advances in organ-on-a-chip systems for modelling joint tissue and osteoarthritic diseases’ Osteoarthritis Cartilage 30 (2022) 1050-1061 by Banh, L., Cheung, K.K., Chan, M.W.Y., Young, E.W.K., Viswanathan, S.

Get full text

Advances in organ-on-a-chip systems for modelling joint tissue and osteoarthritic diseases by Banh, L., Cheung, K.K., Chan, M.W.Y., Young, E.W.K., Viswanathan, S.

“…Joint-on-a-chip (JOC) models are powerful tools that aid in osteoarthritis (OA) research. These microfluidic devices apply emerging organ-on-a-chip technology…”
Get full text

A tool for evaluating novel osteoarthritis therapies using multivariate analyses of human cartilage-synovium explant co-culture by Chan, M.W.Y., Gomez-Aristizábal, A., Mahomed, N., Gandhi, R., Viswanathan, S.

“…There is a need to incorporate multiple tissues into in vitro OA models to evaluate novel therapeutics. This approach is limited by inherent donor variability…”
Get full text

The Implications of Biomarkers Enhancer of Zeste Homolog 2 in Radioresistant Oral cancer by Chen, L.C., Hung, S.K., Lin, H.Y., Lee, M.S., Chiou, W.Y., Chan, M.W.Y., Lin, R.I.

Get full text

Hypermethylation of the PCDHB15 promoter predicts the prognosis in gastric cancer by Lee, Y.-T., Hsu, P.-Y., Chuang, Y.-M., Jin, H., Cheng, A.S.L., Ng, E.K.W., Liu, C.-J., Chen, Y.-C., Cheng, F., Chan, M.W.Y.

Get full text

Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer by Su, P-H, Lin, Y-W, Huang, R-L, Liao, Y-P, Lee, H-Y, Wang, H-C, Chao, T-K, Chen, C-K, Chan, M W Y, Chu, T-Y, Yu, M-H, Lai, H-C

“…Epigenetic modifications are a driving force in carcinogenesis. However, their role in cancer metastasis remains poorly understood. The present study…”
Get full text

Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development by Yang, W, Mok, M T S, Li, M S M, Kang, W, Wang, H, Chan, A W, Chou, J-L, Chen, J, Ng, E K W, To, K-F, Yu, J, Chan, M W Y, Chan, F K L, Sung, J J Y, Cheng, A S L

“…Accumulating evidence reveals the effectiveness of epigenetic therapy in gastric cancer. However, the molecular mechanisms and targets underlying such…”
Get full text

Effect of peroxisome proliferator activated receptor γ ligands on growth and gene expression profiles of gastric cancer cells by Leung, W K, Bai, A H C, Chan, V Y W, Yu, J, Chan, M W Y, To, K-F, Wu, J-R, Chan, K-K, Fu, Y-G, Chan, F K L, Sung, J J Y

“…Background and aims: Although peroxisome proliferator activated receptor γ (PPARγ) agonists have been implicated in differentiation and growth inhibition of…”
Get full text

Alterations of Wnt receptor (FzE3) and secreted frizzled related protein (hsFRP) expression in gastric cancer by To, K.F., Chan, M.W.Y., Leung, Wai K., Yu, Yun, Lee, T.L., Tong, J.J.H.M., Sung, Joseph J.Y.

Get full text